Improving gene editing tools for health
Next generation transposon vectors for genome engineering
This project is developing advanced tools to precisely insert new genetic material into human cells, which could help treat diseases like cancer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11124722 on NIH RePORTER |
What this research studies
This project aims to create better ways to deliver new genes into human cells. Researchers are improving a system called piggyBac, which acts like molecular scissors to insert DNA. They've redesigned this system based on its 3D structure to make it more effective and precise. The goal is to test these new tools in human cells and eventually in living systems to see if they can be used for cell therapies, such as modifying immune cells to fight cancer.
Who could benefit from this research
Good fit: This foundational research does not directly involve patient participation at this stage, but future clinical applications could benefit patients with genetic diseases or certain cancers.
Not a fit: Patients seeking immediate treatment options would not directly benefit from this early-stage research.
Why it matters
Potential benefit: If successful, this work could lead to more effective gene therapies for various diseases, including new ways to treat cancer by modifying a patient's own cells.
How similar studies have performed: The piggyBac system has been used for over 15 years, and this project builds on recent success in re-engineering it based on its 3D structure.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Wilson, Matthew H — Vanderbilt University Medical Center
- Study coordinator: Wilson, Matthew H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.